Department of Medical Microbiology, Faculty of Basic Clinical Sciences, College of Health Sciences, Usmanu Danfodiyo University; Department of Medical Microbiology, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Department of Surgery, Urology Unit, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Ann Afr Med. 2024 Jan-Mar;23(1):40-45. doi: 10.4103/aam.aam_141_23.
In spite of its global notoriety and WHO alarm, Acinetobacter baumannii is still an understudied critical-priority pathobiont in Nigeria. We characterized its antimicrobial susceptibility profile and resistance genes during an outbreak.
This cross-sectional study involved collection of patients' urine samples and swabs from unit staff's hands and ward environments for the identification of A. baumannii strains using standard morphologic and biochemical methods. The disk diffusion method was used to assess the antimicrobial susceptibility profile of the isolates with the production of extended-spectrum beta-lactamases (ESBLs) confirmed by the combined disk test screening method. Characterization of the resistance genes of the ESBL producers was carried out using polymerase chain reaction polymerase chain reaction technique.
A.
total of eight (six clinical and two nonclinical) A. baumannii isolates were identified. The overall isolate susceptibility and resistance rates to all the antimicrobial agents was 56.3% (27/48) and 35.4% (17/48), respectively. Similarly, all (8/8; 100.00%) isolates were susceptible to meropenem and 75.0% (6/8) to ampicillin-sulbactam while 62.5% (5/8) were resistant to trimethoprim-sulfamethoxazole and 50.0% (4/8) to each of ciprofloxacin and ceftazidime. In addition, 37.5% (3/8) of the isolates were multidrug resistant (MDR) with nonclinical isolates exhibiting more antimicrobial resistance than their clinical counterparts (9/12%-75.0% vs. 8/36%-22.2%). Phenotypic detection and molecular characterization revealed three ESBL-producing isolates that each harbored bla and bla genes with bla gene being absent.
MDR strains of A. baumannii harboring bla and bla genes were recovered from clinical and environmental sources during the outbreak, which was contained with preventive measures recommended.
尽管鲍曼不动杆菌在全球声名狼藉,世界卫生组织也发出警报,但它仍然是尼日利亚研究不足的重点优先条件致病菌。我们在一次疫情爆发期间对其抗菌药物敏感性特征和耐药基因进行了研究。
这是一项横断面研究,涉及采集患者尿液样本和医护人员手部拭子以及病房环境样本,通过标准形态学和生物化学方法鉴定鲍曼不动杆菌菌株。采用纸片扩散法评估分离株的抗菌药物敏感性谱,通过联合纸片试验筛选法确产超广谱β-内酰胺酶(ESBLs)。采用聚合酶链反应(PCR)技术对 ESBL 产生菌的耐药基因进行鉴定。
共鉴定出 8 株(6 株临床分离株和 2 株非临床分离株)鲍曼不动杆菌。所有抗菌药物的总分离株敏感性和耐药率分别为 56.3%(27/48)和 35.4%(17/48)。同样,所有(8/8;100.00%)分离株均对美罗培南敏感,87.5%(7/8)对氨苄西林-舒巴坦敏感,62.5%(5/8)对复方磺胺甲噁唑耐药,50.0%(4/8)对环丙沙星和头孢他啶耐药。此外,37.5%(3/8)的分离株为多重耐药(MDR),非临床分离株的抗菌药物耐药性高于临床分离株(9/12%-75.0%比 8/36%-22.2%)。表型检测和分子特征鉴定显示,从临床和环境来源中分离出 3 株产 ESBL 的分离株,它们分别携带 bla 和 bla 基因,而 bla 基因缺失。
在疫情期间,从临床和环境来源中回收了携带 bla 和 bla 基因的 MDR 鲍曼不动杆菌菌株,通过推荐的预防措施得到了控制。